Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 78
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method | Mastronardi C, Schubert P, Levin E, Bhakta V, Yi QL, Hansen A, Stewart T, Jenkins C, Lefresne W, Sheffield W, Acker JP | 2013 | J Blood Transfus | View Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method | Blood operators | New or improved product or process |
ResearchUnit: What is the utility of selecting platelets by cross-matching? | Shehata N | 2013 | Blood.ca website | View ResearchUnit: What is the utility of selecting platelets by cross-matching? | Other | Other |
Scanning the future of transfusion medicine | Devine D, Dzik WH, Szczepiorkowski ZM | 2013 | Practical Transfusion Medicine, 4th edition | View Scanning the future of transfusion medicine | Health care providers | Other |
The cellular pathophysiology of immune thrombocytopenia | Semple JW | 2013 | ISBT Sci Ser | View The cellular pathophysiology of immune thrombocytopenia | Researchers | Basic research |
Thermal reversal of polyvalent choline phosphate, a multivalent universal biomembrane adhesive | Yu X, Zou Y, Horte S, Janzen J, Kizhakkedathu JN, Brooks DE | 2013 | Biomacromolecules | View Thermal reversal of polyvalent choline phosphate, a multivalent universal biomembrane adhesive | Researchers | Basic research |
The rationale for platelet transfusion during cardiopulmonary bypass: an observational study | Zaffar N, Joseph A, Mazer CD, Nisenbaum R, Karkouti K, Tinmouth A, Peterson MD, Pavenski K, Callum J, Cserti-Gazdewich C, Shehata N | 2013 | Can J Anaesth | View The rationale for platelet transfusion during cardiopulmonary bypass: an observational study | Health care providers | Clinical research |
What to do with the queue? Reducing wait times for cancer care | Blake JT, Bolland D, Dawe I | 2013 | Case Studies in Health Policy and Management, 2nd Edition | View What to do with the queue? Reducing wait times for cancer care | Other | Other |
A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia | Arnold DM, Kukaswadia S, Nazi I, Esmail A, Dewar L, Smith JW, Warkentin TE, Kelton JG | 2013 | J Thromb Haemost | View A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia | Health care providers | Clinical research |
Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule | Ramirez-Arcos S, Perkins H, Kou Y, Mastronardi C, Kumaran D, Taha M, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J | 2013 | Vox Sang | View Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule | Regulators | New or improved product or process |
Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Ramirez-Arcos S, Mastronardi C, Perkins H, Kou Y, Turner T, Mastronardi E, Hansen A, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J | 2013 | Transfusion | View Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Regulators | New or improved product or process |
FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Nazi I, Arnold DM, Smith JW, Horsewood P, Moore JC, Warkentin TE, Crowther MA, Kelton JG | 2013 | J Thromb Haemost | View FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Researchers | Basic research |
ResearchUnit: Supporting evidence to change regulations regarding the storage of cryosupernatant plasma. | Sheffield W | 2013 | Blood.ca website | View ResearchUnit: Supporting evidence to change regulations regarding the storage of cryosupernatant plasma. | Other | Other |
The impact of prolonged storage of red blood cells on cancer survival | Kekre N, Mallick R, Allan D, Tinmouth A, Tay J | 2013 | PLoS One | View The impact of prolonged storage of red blood cells on cancer survival | Health care providers | Clinical research |
Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia | Li C, Chen P, Vadasz B, Ma L, Zhou H, Lang S, Freedman J, Ni H | 2013 | Thromb Haemost | View Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia | Researchers | Basic research |
Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions | Hansen A, Yi QL, Acker JP | 2013 | Transfusion | View Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions | Researchers | New or improved product or process |
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness | Arnold DM, Lauzier F, Rabbat C, Zytaruk N, Barlow Cash B, Clarke F, Heels-Ansdell D, Guyatt G, Walter SD, Davies A, Cook DJ, PROTECT Investigators on behalf of the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Clinical Trials Group | 2013 | Thromb Res | View Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness | Researchers | Clinical research |
Challenges in the management of the blood supply | Williamson LM, Devine DV | 2013 | Lancet | View Challenges in the management of the blood supply | Blood operators | Other |
Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition | Roddick LA, Bhakta V, Sheffield W | 2013 | BMC Biochem | View Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition | Researchers | Basic research |
Legal Aspects of the Blood System in Canada | Reis NM | 2013 | Public Health Law and Policy in Canada | View Legal Aspects of the Blood System in Canada | Other | Other |
The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors | O'Brien SF, Goldman M, Scalia V, Yi QL, Fan W, Xi G, Dines IR, Fearon MA | 2013 | Transfus Med | View The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors | Blood operators | Clinical research |
A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada | Fearon MA, Scalia V, Huang M, Dines I, Ndao M | 2013 | Can J Infect Dis Med Microbiol | View A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada | Health care providers | Clinical research |
Positioning new treatments in the management of immune thrombocytopenia | Arnold DM | 2013 | Pediatr Blood Cancer | View Positioning new treatments in the management of immune thrombocytopenia | Researchers | Clinical research |
Rapid removal of glycerol from frozen-thawed red blood cells | Lusianti RE, Benson JD, Acker JP, Higgins AZ | 2013 | Biotechnol Prog | View Rapid removal of glycerol from frozen-thawed red blood cells | Researchers | New or improved product or process |
Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway | Crow AR, Yu H, Han D, Lazarus AH | 2013 | PLoS One | View Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway | Researchers | Basic research |
Donor hemovigilance | Goldman M | 2013 | Blood Transfus | View Donor hemovigilance | Health care providers | Other |
Expert approaches to common bleeding and thrombotic problems, part II | Hayward CP, Webert KE | 2013 | Semin Thromb Hemost | View Expert approaches to common bleeding and thrombotic problems, part II | Health care providers | Other |
Research with Blood Donated to Blood Banking Organizations | Reis NM | 2013 | Health Law Review | View Research with Blood Donated to Blood Banking Organizations | Other | Other |
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation Evaluation for Transfusion Therapies Collaborators | 2013 | Transfusion | View Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Researchers | Clinical research |
A platelet cover-up | Arnold DM | 2013 | Blood | View A platelet cover-up | Researchers | Other |
Legal Foundations of Public Health Law | Reis NM | 2013 | Public Health Law and Policy in Canada | View Legal Foundations of Public Health Law | Other | Other |
Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles | Bicalho B, Holovati JL, Acker JP | 2013 | Biochim Biophys Acta | View Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles | Researchers | Basic research |
The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand | Boyle AJ, Roddick LA, Bhakta V, Lambourne MD, Junop MS, Liaw PC, Weitz JI, Sheffield WP | 2013 | BMC Biochem | View The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand | Researchers | Basic research |
Rejuvenation of ATP during storage does not reverse effects of the hypothermic storage lesion | Tchir JD, Acker JP, Holovati JL | 2013 | Transfusion | View Rejuvenation of ATP during storage does not reverse effects of the hypothermic storage lesion | Researchers | Basic research |
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis | Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D | 2013 | Intensive Care Med | View Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis | Health care providers | Clinical research |
Alloimmunization of patients by blood units harboring distinct DEL variants | St-Louis M, Lebrun A, Goldman M, Lavoie M | 2013 | Immunohematology | View Alloimmunization of patients by blood units harboring distinct DEL variants | Health care providers | Clinical research |
Fc-independent phagocytosis: Implications for IVIG and other therapies in immune-mediated thrombocytopenia | Li J, van der Wal DE, Zhu L, Vadasz B, Simpson EK, Li C, Webster ML, Zhu G, Lang S, Chen P, Zeng Q, Ni H | 2013 | Cardiovasc Hematol Disord Drug Targets | View Fc-independent phagocytosis: Implications for IVIG and other therapies in immune-mediated thrombocytopenia | Researchers | Other |
Identifying D-positive donors using a second automated testing platform | Goldman M, Resz I, Cote J, Ochoa G, Angus N | 2013 | Immunohematology | View Identifying D-positive donors using a second automated testing platform | Blood operators | New or improved product or process |
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment | Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV | 2013 | Transfusion | View Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment | Researchers | Basic research |
Standardization of CD62P measurement: results of an international comparative study | Levin E, Serrano K, Devine DV, for the Biomedical Excellence for Safer Transfusion Collaborative | 2013 | Vox Sang | View Standardization of CD62P measurement: results of an international comparative study | Blood operators | Benchmarking and standard setting |
The use of the electronic (computer) cross-match | Reesink HW, Davis K, Wong J, Schwartz DW, Mayr WR, Devine DV, Georgsen J, Chiaroni J, Ferrera V, Roubinet F, Lin CK, O'Donovan B, Fitzgerald JM, Raspollini E, Villa S, Rebulla P, Makino S, Gounder D, Safwenberg J, Murphy MF, Staves J, Milkins C, Mercado TC, Illoh OC, Panzer S | 2013 | Vox Sang | View The use of the electronic (computer) cross-match | Blood operators | Benchmarking and standard setting |
CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide | Kim M, Binnington B, Sakac D, Lingwood CA, Branch DR | 2013 | AIDS | View CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide | Researchers | Basic research |
Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues | Trant JF, Briggs RA, Capicciotti C, Ben RN | 2013 | RSC Adv | View Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues | Researchers | Basic research |
ResearchUnit: Should patients receive HLA-selected platelets? | Shehata N | 2013 | Blood.ca website | View ResearchUnit: Should patients receive HLA-selected platelets? | Other | Other |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |
Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma | Talbot K, Meixner SC, Pryzdial EL | 2013 | Biochim Biophys Acta | View Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma | Researchers | Basic research |
ResearchUnit: How does consolidation of blood production and distribution services impact hospitals? | Blake J | 2013 | Blood.ca website | View ResearchUnit: How does consolidation of blood production and distribution services impact hospitals? | Other | Other |
Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain | Kurbegovic A, Trudel M | 2013 | Hum Mol Genet | View Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain | Researchers | Basic research |
ResearchUnit: Doubling the 30-minute rule without compromising Red Blood Cells quality and safety. | Ramirez-Arcos S | 2013 | Blood.ca website | View ResearchUnit: Doubling the 30-minute rule without compromising Red Blood Cells quality and safety. | Other | Other |
Thrombocytopenia in the critically ill | Shehata N, Fontes ML | 2013 | Can J Anaesth | View Thrombocytopenia in the critically ill | Researchers | Other |
Quality of frozen transfusable plasma prepared from whole blood donations in Canada: An update | Sheffield WP, Bhakta V, Talbot K, Pryzdial ELG, Jenkins C | 2013 | Transfus Apher Sci | View Quality of frozen transfusable plasma prepared from whole blood donations in Canada: An update | Blood operators | Benchmarking and standard setting |